Literature DB >> 3491784

The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

P Möller, B Lämmler, B Herrmann, H F Otto, G Moldenhauer, F Momburg.   

Abstract

Eight cases of the recently reported 'primary mediastinal clear cell lymphoma of B-cell type' (Möller et al., 1986) were examined immunohistologically for the expression of cytoplasmic and/or surface antigens of MHC class I and II with mAbs directed against framework determinants of HLA-A,B,C (W6/32; B9.12.1), HLA-DP,DR,DQ (2.06), -DQ (Leu 10; Tü22), -DR (Tü34) gene products, and with mAbs specific for beta 2-microglobulin (BBM-1) and the HLA-D associated invariant chain (Vic-Y1). Besides the reported Ig-deficiency, the neoplastic B-cells of 7/8 tumours have variable defects in MHC antigen expression. Three lack both class I and class II antigens, one tumour lacks class I antigens but expresses HLA-DQ and -DR on the majority of neoplastic cells, three others contain varying proportions of MHC-antigen deficient tumour cells. The expression of Ii is closely correlated with HLA-D(R) expression and its antigenic sites are strictly located in the cytoplasm. Against the background of current knowledge, the variable and occasionally severe defects in MHC antigen expression within the herein presented series of B-cell lymphomas suggest that this unusual feature might be another characteristic of a novel lymphoma type.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491784      PMCID: PMC1453200     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.

Authors:  F M Brodsky
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

2.  HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays.

Authors:  A Ziegler; B Uchańska-Ziegler; J Zeuthen; P Wernet
Journal:  Somatic Cell Genet       Date:  1982-11

3.  Clinical relevance of immunologic phenotype in diffuse large cell lymphoma.

Authors:  S J Horning; R S Doggett; R A Warnke; R F Dorfman; R S Cox; R Levy
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

4.  Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.

Authors:  M Barcos; J Minowada; K Minato; C Pollard; M Cancino; T Han; E Henderson; H Ozer
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

5.  Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies.

Authors:  B Malissen; N Rebai; A Liabeuf; C Mawas
Journal:  Eur J Immunol       Date:  1982-09       Impact factor: 5.532

6.  Prostaglandins modulate macrophage Ia expression.

Authors:  D S Snyder; D I Beller; E R Unanue
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

7.  A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).

Authors:  V Quaranta; O Majdic; G Stingl; K Liszka; H Honigsmann; W Knapp
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes.

Authors:  R Palacios; O Martinez-Maza; K Guy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

9.  Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo.

Authors:  J Rhodes; D H Jones; N M Bleehen
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Induction of HLA-DC/DS (LEU 10) antigen expression by human precursor B cell lines.

Authors:  C Y Wang; A Al-Katib; C L Lane; B Koziner; S M Fu
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  13 in total

1.  Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.

Authors:  Sarah T Wilkinson; Kristie A Vanpatten; Diane R Fernandez; Patrick Brunhoeber; Karl E Garsha; Betty J Glinsmann-Gibson; Thomas M Grogan; Julie Teruya-Feldstein; Lisa M Rimsza
Journal:  Blood       Date:  2011-12-13       Impact factor: 22.113

Review 2.  Tumours of the thymus and their nomenclature.

Authors:  H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  [Mediastinal large B-cell lymphoma].

Authors:  T F E Barth; P Möller
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

4.  Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.

Authors:  Bjoern Chapuy; Chip Stewart; Andrew J Dunford; Jaegil Kim; Kirsty Wienand; Atanas Kamburov; Gabriel K Griffin; Pei-Hsuan Chen; Ana Lako; Robert A Redd; Claire M Cote; Matthew D Ducar; Aaron R Thorner; Scott J Rodig; Gad Getz; Margaret A Shipp
Journal:  Blood       Date:  2019-12-26       Impact factor: 22.113

5.  Gene expression profiling of gray zone lymphoma.

Authors:  Clémentine Sarkozy; Lauren Chong; Katsuyoshi Takata; Elizabeth A Chavez; Tomoko Miyata-Takata; Gerben Duns; Adèle Telenius; Merrill Boyle; Graham W Slack; Camille Laurent; Pedro Farinha; Thierry J Molina; Christiane Copie-Bergman; Diane Damotte; Gilles A Salles; Anja Mottok; Kerry J Savage; David W Scott; Alexandra Traverse-Glehen; Christian Steidl
Journal:  Blood Adv       Date:  2020-06-09

6.  Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.

Authors:  Mary Gerrard; Ian M Waxman; Richard Sposto; Anne Auperin; Sherrie L Perkins; Stanton Goldman; Lauren Harrison; Ross Pinkerton; Keith McCarthy; Martine Raphael; Catherine Patte; Mitchell S Cairo
Journal:  Blood       Date:  2012-11-13       Impact factor: 22.113

Review 7.  How I treat primary mediastinal B-cell lymphoma.

Authors:  Lisa Giulino-Roth
Journal:  Blood       Date:  2018-07-05       Impact factor: 22.113

8.  Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.

Authors:  L J Medeiros; A B Gelb; K Wolfson; R Doggett; B McGregor; R S Cox; S J Horning; R A Warnke
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 9.  Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?

Authors:  Marian Nassef Kadry Naguib Roufaiel; James W Wells; Raymond J Steptoe
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

10.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.